ArticleBMC cancer2026
Factors contributing to the missed diagnosis of incidental gallbladder cancer (IGBC): an integrated analysis of clinical features and ultrasound radiomics.
Article in BMC cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundIncidental gallbladder cancer (IGBC) is often diagnosed only during or after cholecystectomy, and preoperative identification remains challenging. This study preliminarily explored factors contributing to IGBC missed diagnosis and attempted to develop an ultrasound radiomics‑based identification model.
methodsA retrospective cohort of 62 IGBC and 78 non‑incidental GBC (NIGBC) patients who were consecutively enrolled between 2016/01-2025/12 was analyzed. Clinical, laboratory, imaging, pathological, and immunohistochemical features were compared. From ultrasound images, 1220 radiomics features were extracted; after stability (ICC > 0.75), redundancy removal (Spearman |ρ|> 0.90), and LASSO regression, nine features were retained. Seven machine learning algorithms were used to exploratorily build radiomics‑only models. Potential clinical predictors were identified by logistic regression, and a clinical‑only and a combined model were attempted. Performance was preliminarily evaluated using area under the curve (AUC).
resultsIGBC showed higher gallstone prevalence (91.9% vs. 53.8%, P < 0.001) and a "benign masquerade" laboratory profile (higher albumin (ALB), high-density lipoprotein cholesterol (HDL‑C); lower ratio of albumin to globulin (RAR); fewer elevated CA19‑9). Pathologically, IGBC was predominantly infiltrative (77.4% vs. 28.2%, P < 0.001), had earlier T stage compared to NIGBC (27.4% vs. 12.8%, P = 0.007), and exhibited lower Ki‑67 high expression (67.7% vs. 83.3%, P = 0.031) and weaker Topoisomerase II-alpha (Topo II) staining (P = 0.005). The extreme gradient boosting (XGB) radiomics model achieved a validation AUC of 0.865 (accuracy 0.833), suggesting potential discriminative ability. Gallstones (OR = 9.484) and growth pattern (OR = 0.230) might be independent clinical predictors. The clinical‑only model had AUC 0.830, and the combined model AUC 0.860, with no significant benefit over radiomics‑only.
conclusionPreoperative missed diagnosis of IGBC may be associated with gallstone‑related inflammation, infiltrative growth, early T stage, seemingly normal laboratory findings, and low proliferation marker expression. Although conventional ultrasound hardly identifies IGBC, its tumor heterogeneity might be quantified by radiomics. The XGB model showed preliminary ability to distinguish IGBC from NIGBC and holds potential as a non‑invasive tool for preoperative risk stratification, but findings require validation in larger multicenter cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.